Logo image of MPLN

MULTIPLAN CORP (MPLN) Stock Fundamental Analysis

NYSE:MPLN - New York Stock Exchange, Inc. - US62548M2098 - Common Stock - Currency: USD

23.15  -0.36 (-1.53%)

After market: 23.15 0 (0%)

Fundamental Rating

2

MPLN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. Both the profitability and financial health of MPLN have multiple concerns. MPLN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MPLN had negative earnings in the past year.
In the past year MPLN had a positive cash flow from operations.
MPLN had negative earnings in 4 of the past 5 years.
Each year in the past 5 years MPLN had a positive operating cash flow.
MPLN Yearly Net Income VS EBIT VS OCF VS FCFMPLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

MPLN has a Return On Assets (-31.95%) which is comparable to the rest of the industry.
The Return On Equity of MPLN (-1958.81%) is worse than 81.58% of its industry peers.
MPLN has a Return On Invested Capital of 1.58%. This is in the better half of the industry: MPLN outperforms 76.32% of its industry peers.
MPLN had an Average Return On Invested Capital over the past 3 years of 2.41%. This is below the industry average of 7.17%.
Industry RankSector Rank
ROA -31.95%
ROE -1958.81%
ROIC 1.58%
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
MPLN Yearly ROA, ROE, ROICMPLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

The Operating Margin of MPLN (10.63%) is better than 92.11% of its industry peers.
MPLN's Operating Margin has declined in the last couple of years.
MPLN has a Gross Margin of 74.27%. This is amongst the best in the industry. MPLN outperforms 84.21% of its industry peers.
MPLN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.63%
PM (TTM) N/A
GM 74.27%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
MPLN Yearly Profit, Operating, Gross MarginsMPLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

MPLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MPLN has about the same amout of shares outstanding than it did 1 year ago.
MPLN has less shares outstanding than it did 5 years ago.
MPLN has a worse debt/assets ratio than last year.
MPLN Yearly Shares OutstandingMPLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPLN Yearly Total Debt VS Total AssetsMPLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -0.30, we must say that MPLN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.30, MPLN perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
MPLN has a Debt/Equity ratio of 53.67. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 53.67, MPLN is not doing good in the industry: 81.58% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 53.67
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACC0.25
WACC6.29%
MPLN Yearly LT Debt VS Equity VS FCFMPLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 0.82 indicates that MPLN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, MPLN is doing worse than 76.32% of the companies in the same industry.
A Quick Ratio of 0.82 indicates that MPLN may have some problems paying its short term obligations.
MPLN has a Quick ratio of 0.82. This is in the lower half of the industry: MPLN underperforms 71.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
MPLN Yearly Current Assets VS Current LiabilitesMPLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

MPLN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1059.83%.
Looking at the last year, MPLN shows a decrease in Revenue. The Revenue has decreased by -3.21% in the last year.
Measured over the past years, MPLN shows a decrease in Revenue. The Revenue has been decreasing by -1.09% on average per year.
EPS 1Y (TTM)-1059.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-327%
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%-4.9%

3.2 Future

The Earnings Per Share is expected to grow by 36.67% on average over the next years. This is a very strong growth
Based on estimates for the next years, MPLN will show a small growth in Revenue. The Revenue will grow by 2.09% on average per year.
EPS Next Y87.02%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.75%
Revenue Next 2Y2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MPLN Yearly Revenue VS EstimatesMPLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MPLN Yearly EPS VS EstimatesMPLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MPLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MPLN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MPLN Price Earnings VS Forward Price EarningsMPLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

MPLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MPLN is cheaper than 94.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.19
MPLN Per share dataMPLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

A more expensive valuation may be justified as MPLN's earnings are expected to grow with 36.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.67%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MPLN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MULTIPLAN CORP

NYSE:MPLN (2/27/2025, 8:04:01 PM)

After market: 23.15 0 (0%)

23.15

-0.36 (-1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-06 2025-05-06
Inst Owners47.86%
Inst Owner Change-2.03%
Ins Owners6%
Ins Owner Change0.57%
Market Cap375.03M
Analysts77.78
Price Target13.94 (-39.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.46%
Min EPS beat(2)-73.58%
Max EPS beat(2)14.65%
EPS beat(4)2
Avg EPS beat(4)-370.31%
Min EPS beat(4)-1467.36%
Max EPS beat(4)45.02%
EPS beat(8)5
Avg EPS beat(8)-168.93%
EPS beat(12)6
Avg EPS beat(12)-282.74%
EPS beat(16)9
Avg EPS beat(16)-181.58%
Revenue beat(2)0
Avg Revenue beat(2)-3.09%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-2.88%
Revenue beat(4)0
Avg Revenue beat(4)-4.72%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)-2.88%
Revenue beat(8)2
Avg Revenue beat(8)-2.62%
Revenue beat(12)3
Avg Revenue beat(12)-3.01%
Revenue beat(16)6
Avg Revenue beat(16)-1.99%
PT rev (1m)26.15%
PT rev (3m)24.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25.28%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.98%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)2.01%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF 3.48
P/B 4.46
P/tB N/A
EV/EBITDA 9.19
EPS(TTM)-69.59
EYN/A
EPS(NY)-9.03
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)6.64
OCFY28.7%
SpS57.45
BVpS5.19
TBVpS-280.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.95%
ROE -1958.81%
ROCE 2%
ROIC 1.58%
ROICexc 1.59%
ROICexgc 26.88%
OM 10.63%
PM (TTM) N/A
GM 74.27%
FCFM N/A
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
ROICexc(3y)2.48%
ROICexc(5y)N/A
ROICexgc(3y)66.67%
ROICexgc(5y)N/A
ROCE(3y)3.05%
ROCE(5y)N/A
ROICexcg growth 3Y-40.96%
ROICexcg growth 5Y-27.14%
ROICexc growth 3Y-26.84%
ROICexc growth 5Y-14.89%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 53.67
Debt/FCF N/A
Debt/EBITDA 8.49
Cap/Depr 27.34%
Cap/Sales 12.69%
Interest Coverage 0.31
Cash Conversion 20.27%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z -0.3
F-Score3
WACC6.29%
ROIC/WACC0.25
Cap/Depr(3y)25.06%
Cap/Depr(5y)22.79%
Cap/Sales(3y)10.77%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1059.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-327%
EPS Next Y87.02%
EPS Next 2Y36.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.21%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%-4.9%
Revenue Next Year0.75%
Revenue Next 2Y2.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.76%
EBIT growth 3Y-37.5%
EBIT growth 5Y-23.25%
EBIT Next Year144.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-116.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.33%
OCF growth 3Y-35.69%
OCF growth 5Y-17.66%